Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Expansions of in-house R&D will have no impact on CROs, say Pfizer and Lilly

Despite expanding their in-house R&D facilities, both Pfizer and Eli Lilly say they remain committed to using CROs.

Growth in biopharma industry buttressing Quintiles’ quarterly earnings

Consistent Q2 growth for the world’s largest CRO (contract research organization) Quintiles was driven by a spike in the company’s Integrated Healthcare Services (IHS) segment.

Covance acquisition begins paying off for LabCorp in Q2

LabCorp revealed a more than 46% increase in quarterly revenue from the same quarter last year as the recent $6.2bn acquisition of Covance brought in $620.8m of the overall company’s $2.2bn in Q2.

Icon puts up record net new business wins in Q2

CRO (contract research organization) Icon reported its highest level of quarterly bookings ever on Tuesday and the company’s stock jumped by about 15%. 


CRO vs HRA trial transparency case ends in a win for industry

A five-month legal battle over the duties of trial sponsors to publish results has ended with a judge ruling the UK regulator acted unlawfully and sponsors will not be required to publicly register UK Phase I adult trials from before September 2013.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...